低危HPV阳性口咽癌单枚阳性淋巴结:手术加放疗与单纯手术生存相当
本研究利用美国国家癌症数据库,对HPV阳性口咽鳞状细胞癌且仅有1枚直径<6 cm阳性淋巴结、手术切缘阴性的患者进行生存和多因素分析,发现手术加辅助放疗与单纯手术的5年生存率相当,多因素分析中总生存风险比无显著差异。
要点
- 切缘阴性HPV阳性口咽癌仅1枚<6 cm阳性淋巴结者,加或不加辅助放疗生存相当。
- 该常见亚组目前管理推荐不明确,导致治疗异质性。
- 需随机对照试验进一步验证该特定人群的结局。
核心结论
- 切缘阴性HPV阳性口咽鳞状细胞癌仅1枚<6 cm阳性淋巴结患者,手术加辅助放疗与单纯手术生存相当。
研究设计与样本
- 利用美国国家癌症数据库对HPV阳性口咽鳞状细胞癌仅1枚<6 cm阳性淋巴结且手术切缘阴性患者进行生存和多因素分析。
主要发现
- 手术加辅助放疗与单纯手术的5年生存率相当。
- 多因素分析调整多种潜在混杂因素后,总生存风险比无显著差异。
临床怎么用
- 该常见亚组管理推荐不明确,治疗存在异质性,本数据提示可考虑不加辅助放疗但需个体化。
局限性
- 需随机对照试验进一步评估该特定人群结局以验证初步观察。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For human papilloma virus positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC), management recommendations for patients with a single metastatic lymph node <6 cm in diameter remain nebulous, leading to treatment heterogeneity in this common subgroup of patients. METHODS: We utilized the National Cancer Database to perform survival and multivariable analyses of patients with HPV+ OPSCC with one positive lymph node <6 cm and negative surgical margins. RESULTS: We found that 5-year survival is comparable between patients who receive surgery and adjuvant radiation versus surgery alone. In multivariable analyses, we found no significant difference in the hazard ratio of overall survival after adjusting for various potential confounders. CONCLUSIONS: These data suggest that patients with margin-negative HPV+ OPSCC with a single positive lymph node <6 cm have comparable survival with or without adjuvant radiation. Future studies exploring outcomes for this specific group in randomized-controlled trials will be critical for further evaluating these initial observations.
引用
- Sample RA, Wood CB, Mazul AL, et al. Low-risk human papilloma virus positive oropharyngeal cancer with one positive lymph node: Equivalent outcomes in patients treated with surgery and radiation therapy versus surgery alone. Head Neck. 2021. PMID: 33586842. doi:10.1002/hed.26642
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。